Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
description Rank Gene Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 451 to 500 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bup protein. [source:refseq;acc:nm\_012071]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2911\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bystin. [source:swissprot;acc:q13895]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1149\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
239.505\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
233.185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0271\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
c-1-tetrahydrofolate synthase, cytoplasmic (c1-thf synthase) [includes: methylenetetrahydrofolate dehydrogenase (ec 1.5.1.5); methenyltetrahydrofolate cyclohydrolase (ec 3.5.4.9); formyltetrahydrofolate synthetase (ec 6.3.4.3)]. [source:swissprot;acc:p11586]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1766\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
228.932\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
231.732\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01223\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
c-jun-amino-terminal kinase interacting protein 3 (jnk-interacting protein 3) (jip-3) (jnk map kinase scaffold protein 3) (mitogen- activated protein kinase 8-interacting protein 3). [source:swissprot;acc:q9upt6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2473\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.644\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.991\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.003\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
c-terminal binding protein 1 (ctbp1). [source:swissprot;acc:q13363]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1554\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
196.215\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
193.018\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01656\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
c-terminal binding protein 2 (ctbp2). [source:swissprot;acc:p56545]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1558\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
196.171\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
192.977\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01655\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
c-type lectin superfamily member 1 precursor (cartilage-derived c-type lectin). [source:swissprot;acc:o75596]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
844\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
178.033\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
170.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04223\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
c1 domain-containing phosphatase and tensin-like protein isoform 2; putative protein tyrosine phosphatase; c1 domain-containing phosphatase and tensin-like protein; tensin 2. [source:refseq;acc:nm\_015319]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2475\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.219\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.571\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00298\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
c18b11 homolog (44.9kd). [source:refseq;acc:nm\_152260]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1625\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.446\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01515\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
c316g12.2 (novel protein similar to predicted yeast, worm and archae- bacterial proteins) (similar to und313) (s. cervisiae) (hypothetical protein). [source:sptrembl;acc:q9ujk0]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1506\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.103\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.339\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01807\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
c367g8.3 (novel protein similar to rpl23a (60s ribosomal protein l23a)) (60s ribosomal protein l23a like). [source:sptrembl;acc:q9br02]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
321\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
241.892\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
265.959\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09949\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
c439a6.1 (novel protein similar to heparan sulfate (glucosamine) 3-o- sulfotransferases) (fragment). [source:sptrembl;acc:q96qi5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
260\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
219.421\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
196.978\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11394\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ca2+-dependent endoplasmic reticulum nucleoside diphosphatase; apyrase; soluble calcium-activated nucleotidase scan-1. [source:refseq;acc:nm\_138793]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2577\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
192.625\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
192.922\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00154\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
caax prenyl protease 1 homolog (ec 3.4.24.-) (prenyl protein-specific endoprotease 1) (farnesylated-proteins converting enzyme 1) (face-1) (zinc metalloproteinase ste24 homolog). [source:swissprot;acc:o75844]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1448\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
226.532\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.117\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01988\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cab2. [source:refseq;acc:nm\_033419]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
769\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
210.946\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.225\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04873\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cad protein [includes: glutamine-dependent carbamoyl-phosphate synthase (ec 6.3.5.5); aspartate carbamoyltransferase (ec 2.1.3.2); dihydroorotase (ec 3.5.2.3)]. [source:swissprot;acc:p27708]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1829\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.884\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.323\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01146\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cadherin-related tumor suppressor homolog precursor (fat protein homolog). [source:swissprot;acc:q14517]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1526\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
219.306\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.179\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01766\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calcipressin 1 (down syndrome critical region protein 1) (myocyte- enriched calcineurin interacting protein 1) (mcip1) (adapt78). [source:swissprot;acc:p53805]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1330\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.508\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.648\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02275\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
calcipressin 2 (thyroid hormone-responsive protein zaki-4) (down syndrome candidate region 1-like 1) (myocyte-enriched calcineurin interacting protein 2) (mcip2). [source:swissprot;acc:q14206]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1328\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
218.509\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
213.649\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
calcipressin 3 (down syndrome candidate region 1-like protein 2) (myocyte-enriched calcineurin interacting protein 3) (mcip3). [source:swissprot;acc:q9uka8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1331\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calcium-binding mitochondrial carrier protein aralar1 (solute carrier family 25, member 12). [source:swissprot;acc:o75746]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2494\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
194.527\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
195.08\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00284\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
calcium-binding mitochondrial carrier protein aralar2 (solute carrier family 25, member 13) (citrin). [source:swissprot;acc:q9ujs0]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2497\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calcium-dependent protease, small subunit (calpain regulatory subunit) (calcium-activated neutral proteinase) (canp). [source:swissprot;acc:p04632]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
940\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.442\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.088\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03586\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calcium-transporting atpase type 2c, member 1 (ec 3.6.3.8) (atpase 2c1) (atp-dependent ca(2+) pump pmr1) (hussy-28). [source:swissprot;acc:p98194]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1100\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
209.052\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.183\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02889\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calcium/calmodulin-dependent protein kinase type ii alpha chain (ec 2.7.1.123) (cam-kinase ii alpha chain) (cam kinase ii alpha subunit) (camk-ii alpha subunit). [source:swissprot;acc:q9uqm7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2172\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
215.925\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
214.481\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00673\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
calcium/calmodulin-dependent protein kinase type ii beta chain (ec 2.7.1.123) (cam-kinase ii beta chain) (cam kinase ii beta subunit) (camk-ii beta subunit). [source:swissprot;acc:q13554]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2173\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
calcium/calmodulin-dependent protein kinase type ii delta chain (ec 2.7.1.123) (cam-kinase ii delta chain) (cam kinase ii delta subunit) (camk-ii delta subunit). [source:swissprot;acc:q13557]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2162\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
calcium/calmodulin-dependent protein kinase type ii gamma chain (ec 2.7.1.123) (cam-kinase ii gamma chain) (cam kinase ii gamma subunit) (camk-ii gamma subunit) (fragment). [source:swissprot;acc:q13555]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2161\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calcyphosine. [source:swissprot;acc:q13938]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
563\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.744\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.121\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06577\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calmegin precursor. [source:swissprot;acc:o14967]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1909\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.256\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01033\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calmodulin. [source:swissprot;acc:p02593]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2928\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calnexin precursor (major histocompatibility complex class i antigen-binding protein p88) (p90) (ip90). [source:swissprot;acc:p27824]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1910\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.256\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01033\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calpain 1, large [catalytic] subunit (ec 3.4.22.17) (calcium-activated neutral proteinase) (canp) (mu-type) (mucanp) (micromolar-calpain). [source:swissprot;acc:p07384]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
299\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
268.635\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.592\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.10281\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
calpain 2, large [catalytic] subunit precursor (ec 3.4.22.17) (calcium-activated neutral proteinase) (canp) (m-type) (m-calpain) (millimolar-calpain) (calpain large polypeptide l2). [source:swissprot;acc:p17655]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
298\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
268.632\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.588\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calreticulin precursor (crp55) (calregulin) (hacbp) (erp60). [source:swissprot;acc:p27797]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2181\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
227.117\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00664\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calsyntenin-1 precursor. [source:swissprot;acc:o94985]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2699\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
188.435\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
188.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00066\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calsyntenin-2 precursor. [source:swissprot;acc:q9h4d0]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2705\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
188.457\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
188.334\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00065\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
calsyntenin-3 precursor. [source:swissprot;acc:q9bqt9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2706\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
188.459\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
188.336\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
camp response element-binding protein cre-bpa. [source:refseq;acc:nm\_004904]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1363\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.591\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.899\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02194\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
camp responsive element binding protein-like 2. [source:refseq;acc:nm\_001310]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3078\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
camp-dependent protein kinase type i-alpha regulatory chain (tissue- specific extinguisher-1) (tse1). [source:swissprot;acc:p10644]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3089\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
camp-dependent protein kinase type ii-alpha regulatory chain. [source:swissprot;acc:p13861]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2307\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.554\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.467\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00507\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
camp-dependent protein kinase type ii-beta regulatory chain. [source:swissprot;acc:p31323]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2313\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.529\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.449\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00504\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
camp-dependent protein kinase, alpha-catalytic subunit (ec 2.7.1.37) (pka c-alpha). [source:swissprot;acc:p17612]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2312\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
215.542\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
214.459\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00505\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
camp-dependent protein kinase, beta-catalytic subunit (ec 2.7.1.37) (pka c-beta). [source:swissprot;acc:p22694]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2311\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
camp-dependent protein kinase, gamma-catalytic subunit (ec 2.7.1.37) (pka c-gamma). [source:swissprot;acc:p22612]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2309\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
candidate tumor suppressor in ovarian cancer 2. [source:refseq;acc:nm\_080822]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1173\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
229.243\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
235.246\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02619\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
carboxypeptidase a1 precursor (ec 3.4.17.1). [source:swissprot;acc:p15085]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1422\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
203.979\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
208.229\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02084\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
carboxypeptidase a5. [source:refseq;acc:nm\_080385]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1417\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
carboxypeptidase b precursor (ec 3.4.17.2) (pancreas-specific protein) (pasp). [source:swissprot;acc:p15086]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1418\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/